نتایج جستجو برای: friedreich ataxia frda

تعداد نتایج: 17926  

Journal: :Human molecular genetics 2000
M Cossée H Puccio A Gansmuller H Koutnikova A Dierich M LeMeur K Fischbeck P Dollé M Koenig

Friedreich ataxia (FRDA), the most common autosomal recessive ataxia, is caused in almost all cases by homozygous intronic expansions resulting in the loss of frataxin, a mitochondrial protein conserved through evolution, and involved in mitochondrial iron homeostasis. Yeast knockout models, and histological and biochemical data from patient heart biopsies or autopsies indicate that the frataxi...

Journal: :Genomics 2006
Sahar Al-Mahdawi Ricardo Mouro Pinto Dhaval Varshney Lorraine Lawrence Margaret B Lowrie Sian Hughes Zoe Webster Julian Blake J Mark Cooper Rosalind King Mark A Pook

Friedreich ataxia (FRDA) is a neurodegenerative disorder caused by an unstable GAA repeat expansion mutation within intron 1 of the FXN gene. However, the origins of the GAA repeat expansion, its unstable dynamics within different cells and tissues, and its effects on frataxin expression are not yet completely understood. Therefore, we have chosen to generate representative FRDA mouse models by...

Journal: :Human molecular genetics 2000
P Cavadini C Gellera P I Patel G Isaya

Frataxin is a nuclear-encoded mitochondrial protein widely conserved among eukaryotes. Human frataxin (fxn) is severely reduced in Friedreich ataxia (FRDA), a frequent autosomal recessive neuro- and cardio-degenerative disease. Whereas the function of fxn is unknown, the yeast frataxin homolog (Yfh1p) has been shown to be involved in mitochondrial iron homeostasis and protection from free radic...

Journal: :Brain : a journal of neurology 2008
Gary Rance Rosanne Fava Heath Baldock April Chong Elizabeth Barker Louise Corben Martin B Delatycki

The aim of this study was to investigate auditory pathway function and speech perception ability in individuals with Friedreich ataxia (FRDA). Ten subjects confirmed by genetic testing as being homozygous for a GAA expansion in intron 1 of the FXN gene were included. While each of the subjects demonstrated normal, or near normal sound detection, 3 of the 10 showed electrophysiological evidence ...

2013
Lingli Li Lucille Voullaire Chiranjeevi Sandi Mark A. Pook Panos A. Ioannou Martin B. Delatycki Joseph P. Sarsero

Friedreich ataxia (FRDA) is an autosomal recessive disorder characterized by neurodegeneration and cardiomyopathy. The presence of a GAA trinucleotide repeat expansion in the first intron of the FXN gene results in the inhibition of gene expression and an insufficiency of the mitochondrial protein frataxin. There is a correlation between expansion length, the amount of residual frataxin and the...

2014
Grazia Isaya

Growing evidence supports a role for mitochondrial iron metabolism in the pathophysiology of neurodegenerative disorders such as Friedreich ataxia (FRDA) and Parkinson disease (PD) as well as in the motor and cognitive decline associated with the aging process. Iron-sulfur enzyme deficits and regional iron accumulation have been observed in each of these conditions. In spite of significant etio...

2016
Semiha Kurt Betul Cevik Durdane Aksoy E Irmak Sahbaz Aslı Gundogdu Eken A Nazli Basak

Here, we describe the clinical features of several members of the same family diagnosed with Friedreich ataxia (FRDA) and cerebral lesions, demyelinating neuropathy, and late-age onset without a significant cardiac involvement and presenting with similar symptoms, although genetic testing was negative for the GAA repeat expansion in one patient of the family. The GAA repeat expansion in the fra...

Journal: :Movement disorders : official journal of the Movement Disorder Society 2012
David R Lynch Steven M Willi Robert B Wilson M Grazia Cotticelli Karlla W Brigatti Eric C Deutsch Olena Kucheruk William Shrader Patrice Rioux Guy Miller Amale Hawi Thomas Sciascia

This study tested the ability of A0001 (α-tocopheryl quinone; EPI-A0001), a potent antioxidant, to improve in vitro measures, glucose metabolism, and neurological function in Friedreich ataxia. We used an in vitro study of protection from cell toxicity followed by a double-blind, randomized, placebo-controlled trial of 2 doses of A0001 in 31 adults with Friedreich ataxia. The primary clinical t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید